Modern medicine relies on our ability to genetically engineer cells and turn them into miniature protein production plants. The trouble is that, in addition to expressing the material that is desired ...
A meta-analysis spanning more than 100 cardiology RCTs over three decades in more than a million patients offers a stern rebuke to the notion that nonfatal MI can serve as a surrogate for mortality, ...
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results